166 related articles for article (PubMed ID: 11169212)
1. IgG subclass profile of serum antigliadin antibodies and antibody-dependent cell-mediated cytotoxicity in young children with coeliac disease.
Saalman R; Dahlgren UI; Fällström SP; Hanson LA; Ahlstedt S; Wold AE
Scand J Immunol; 2001 Jan; 53(1):92-8. PubMed ID: 11169212
[TBL] [Abstract][Full Text] [Related]
2. ADCC-mediating capacity in children with cow's milk protein intolerance in relation to IgG subclass profile of serum antibodies to beta-lactoglobulin.
Saalman R; Dahlgren UI; Fällström SP; Hanson LA; Wold AE; Ahlstedt S
Scand J Immunol; 1995 Jul; 42(1):140-6. PubMed ID: 7631136
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of coeliac disease and other malabsorption diseases using specific serum antigliadin IgG subclass profiles and IgA1 levels.
Gonczi J; Skerritt JH; Mitchell JD
Int Arch Allergy Immunol; 1992; 98(4):377-85. PubMed ID: 1422265
[TBL] [Abstract][Full Text] [Related]
4. Antibody-dependent cell-mediated cytotoxicity to gliadin-coated cells with sera from children with coeliac disease.
Saalman R; Wold AE; Dahlgren UI; Fällström SP; Hanson LA; Ahlstedt S
Scand J Immunol; 1998 Jan; 47(1):37-42. PubMed ID: 9467656
[TBL] [Abstract][Full Text] [Related]
5. Serum IgG subclass antibodies to gliadin and other dietary antigens in children with coeliac disease.
Husby S; Foged N; Oxelius VA; Svehag SE
Clin Exp Immunol; 1986 Jun; 64(3):526-35. PubMed ID: 3791689
[TBL] [Abstract][Full Text] [Related]
6. [Relevance of anti-tissue transglutaminase antibodies in coeliac disease diagnosis].
Lepers S; Soula F; Fily S; Fontaine E; Vuye S; Colombel JF; Guimber D; Prin L; Dubucquoi S
Ann Biol Clin (Paris); 2003; 61(3):337-43. PubMed ID: 12805013
[TBL] [Abstract][Full Text] [Related]
7. Serum IgG subclass antibodies to a variety of food antigens in patients with coeliac disease.
Hvatum M; Scott H; Brandtzaeg P
Gut; 1992 May; 33(5):632-8. PubMed ID: 1612478
[TBL] [Abstract][Full Text] [Related]
8. Gliadin IgG subclass antibodies in patients with coeliac disease.
Ciclitira PJ; Ellis HJ; Richards D; Kemeny DM
Int Arch Allergy Appl Immunol; 1986; 80(3):258-61. PubMed ID: 3721595
[TBL] [Abstract][Full Text] [Related]
9. The subclass profile and complement activating potential of anti-alpha-gliadin antibodies in coeliac disease.
Gallagher RB; Cervi P; Kelly J; Dolan C; Weir DG; Feighery C
J Clin Lab Immunol; 1989 Mar; 28(3):115-21. PubMed ID: 2738909
[TBL] [Abstract][Full Text] [Related]
10. Avidity progression of dietary antibodies in healthy and coeliac children.
Saalman R; Dahlgren UI; Fällström SP; Hanson LA; Ahlstedt S; Wold AE
Clin Exp Immunol; 2003 Nov; 134(2):328-34. PubMed ID: 14616795
[TBL] [Abstract][Full Text] [Related]
11. Quantitative antigliadin antibody measurement in clinical practice: an Italian multicentre study. SIGEP Working Group on Quantitative AGA Standardization.
Catassi C; Fabiani E; Gasparin M; Troncone R
Ital J Gastroenterol Hepatol; 1999; 31(5):366-70. PubMed ID: 10470593
[TBL] [Abstract][Full Text] [Related]
12. Antibody responses to deamidated gliadin peptide show high specificity and parallel antibodies to tissue transglutaminase in developing coeliac disease.
Ankelo M; Kleimola V; Simell S; Simell O; Knip M; Jokisalo E; Tarkia M; Westerlund A; He Q; Viander M; Ilonen J; Hinkkanen AE
Clin Exp Immunol; 2007 Nov; 150(2):285-93. PubMed ID: 17803713
[TBL] [Abstract][Full Text] [Related]
13. Heat shock protein and gliadin peptide promote development of peptidase antibodies in children with autism and patients with autoimmune disease.
Vojdani A; Bazargan M; Vojdani E; Samadi J; Nourian AA; Eghbalieh N; Cooper EL
Clin Diagn Lab Immunol; 2004 May; 11(3):515-24. PubMed ID: 15138176
[TBL] [Abstract][Full Text] [Related]
14. Salivary antigliadin and antiendomysium antibodies in coeliac disease.
Lähteenoja H; Toivanen A; Räihä I; Syrjänen S; Viander M
Scand J Immunol; 1999 Nov; 50(5):528-35. PubMed ID: 10564556
[TBL] [Abstract][Full Text] [Related]
15. Dissociation between systemic and mucosal humoral immune responses in coeliac disease.
O'Mahony S; Arranz E; Barton JR; Ferguson A
Gut; 1991 Jan; 32(1):29-35. PubMed ID: 1991635
[TBL] [Abstract][Full Text] [Related]
16. [The importance of detection of antigliadin antibodies in the diagnosis and therapy of celiac disease in children].
Kolek A; Lochmann I; Tichý M
Cesk Pediatr; 1992 Dec; 47(12):705-8. PubMed ID: 1294309
[TBL] [Abstract][Full Text] [Related]
17. IgG subclass response to HIV in relation to antibody-dependent cellular cytotoxicity at different clinical stages.
Ljunggren K; Broliden PA; Morfeldt-Månson L; Jondal M; Wahren B
Clin Exp Immunol; 1988 Sep; 73(3):343-7. PubMed ID: 3208446
[TBL] [Abstract][Full Text] [Related]
18. IgA1, IgA2 or secretory piece containing antigliadin antibodies in the sera of coeliac patients.
Blanco A; Arranz E; Alonso M; Sánchez Villares E
Allergol Immunopathol (Madr); 1989; 17(2):77-80. PubMed ID: 2773754
[TBL] [Abstract][Full Text] [Related]
19. Identification of common epitopes on gliadin, enterocytes, and calreticulin recognised by antigliadin antibodies of patients with coeliac disease.
Krupicková S; Tucková L; Flegelová Z; Michalak M; Walters JR; Whelan A; Harries J; Vencovský J; Tlaskalová-Hogenová H
Gut; 1999 Feb; 44(2):168-73. PubMed ID: 9895374
[TBL] [Abstract][Full Text] [Related]
20. Production of antibodies to gliadin in intestinal mucosa of patients with coeliac disease: a study at the single cell level.
Lycke N; Kilander A; Nilsson LA; Tarkowski A; Werner N
Gut; 1989 Jan; 30(1):72-7. PubMed ID: 2920930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
